FURTHER CHARACTERIZATION OF THE EFFECTS OF BRAIN-DERIVED NEUROTROPHIC FACTOR AND CILIARY NEUROTROPHIC FACTOR ON AXOTOMIZED NEONATAL AND ADULT MAMMALIAN MOTOR-NEURONS

被引:85
|
作者
CLATTERBUCK, RE
PRICE, DL
KOLIATSOS, VE
机构
[1] JOHNS HOPKINS UNIV, SCH MED, NEUROPATHOL LAB, BALTIMORE, MD 21205 USA
[2] JOHNS HOPKINS UNIV, SCH MED, DEPT PATHOL, BALTIMORE, MD 21205 USA
[3] JOHNS HOPKINS UNIV, SCH MED, DEPT NEUROL, BALTIMORE, MD 21205 USA
[4] JOHNS HOPKINS UNIV, SCH MED, DEPT NEUROSCI, BALTIMORE, MD 21205 USA
关键词
CELL DEATH; CYTOKINES; FACIAL NUCLEUS; NERVE GROWTH FACTOR RECEPTOR; NEUROTROPHINS;
D O I
10.1002/cne.903420106
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Neurotrophins and neural cytokines are two broad classes of neurotrophic factors. It has been reported that ciliary neurotrophic factor (CNTF) and brain-derived neurotrophic factor (BDNF) prevent the degeneration of axotomized neonatal motor neurons. In addition, BDNF is transported retrogradely to alpha-motor neurons following injection into the muscle, and patterns of BDNF expressed in spinal cord and muscle suggest a physiological role for this factor in motor neurons. In the present study, we characterize the effects of BDNF on axotomized neonatal facial motor neurons and extend these observations to adult models of motor neuron injury (axotomy-induced phenotypic injury of lumbar motor neurons). BDNF reduces axotomy-induced degeneration of neonatal neurons by 55% as determined by Nissl staining (percentage of surviving neurons in vehicle-treated cases, 25%; in BDNF-treated cases, 80%). Rescued neurons have an intact organelle structure but appear smaller and slightly chromatolytic on electron microscopic analysis. As demonstrated by intense retrograde labeling with horseradish peroxidase (HRP) applied to the proximal stump of the facial nerve, neurons rescued by BDNF have intact mechanisms of fast axonal transport. CNTF did not appear to have significant effects on neonatal motor neurons, but the lack of efficacy of this factor may be caused by its rapid degradation at the application site. BDNF is not capable of reversing the axotomy-induced reduction in transmitter markers [i.e., the acetylcholine-synthesizing enzyme choline acetyltransferase (ChAT) or the degrading enzyme acetylcholinesterase (AChE)] in neonatal or adult animals or the axotomy-induced up-regulation of the low-affinity neurotrophin receptor p75(NGFR) (nerve growth factor receptor) in adult motor neurons. However, BDNF appears to promote the expression of p75(NGFR) in injured neonatal motor neurons. In concert, the findings of the present study suggest that BDNF can significantly prevent cell death in injured motor neurons. However, this neurotrophin may not be a retrograde signal associated with the induction and/or maintenance of some mature features of motor neurons, particularly their transmitter phenotype. (C) 1994 Wiley-Liss, Inc.
引用
收藏
页码:45 / 56
页数:12
相关论文
共 50 条
  • [41] Mucosal expression of nerve growth factor and brain-derived neurotrophic factor in chronic rhinosinusitis
    Coffey, Charles S.
    Mulligan, Ryan M.
    Schlosser, Rodney J.
    AMERICAN JOURNAL OF RHINOLOGY & ALLERGY, 2009, 23 (06) : 571 - 574
  • [42] Brain-Derived Neurotrophic Factor (BDNF): Role of this neurotrophin in cardiovascular physiopathology
    Lorgis, L.
    Amoureux, S.
    Vergely, C.
    Zeller, M.
    Cottin, Y.
    Rochette, L.
    ANNALES DE CARDIOLOGIE ET D ANGEIOLOGIE, 2009, 58 (02): : 99 - 103
  • [43] Effect of immunomodulatory drugs on in vitro production of brain-derived neurotrophic factor
    Petereit, HF
    Lindemann, H
    Schoppe, S
    MULTIPLE SCLEROSIS JOURNAL, 2003, 9 (01) : 16 - 20
  • [44] Circadian rhythm of brain-derived neurotrophic factor in the rat suprachiasmatic nucleus
    Liang, FQ
    Walline, R
    Earnest, DJ
    NEUROSCIENCE LETTERS, 1998, 242 (02) : 89 - 92
  • [45] SERUM AND URINARY LEVELS OF BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) IN ENURESIS
    Kurku, Huseyin
    Soran, Mustafa
    Yar, Ahmet
    Akdam, Neriman
    Arslan, Sukru
    Gonen, Murat
    ARCHIVOS ESPANOLES DE UROLOGIA, 2019, 72 (10): : 1032 - 1037
  • [46] Journey of brain-derived neurotrophic factor: from intracellular trafficking to secretion
    Masami Kojima
    Chiaki Ishii
    Yoshitake Sano
    Toshiyuki Mizui
    Teiichi Furuichi
    Cell and Tissue Research, 2020, 382 : 125 - 134
  • [47] Preliminary evidence of cannabinoid effects on brain-derived neurotrophic factor (BDNF) levels in humans
    D'Souza, Deepak Cyril
    Pittman, Brian
    Perry, Edward
    Simen, Arthur
    PSYCHOPHARMACOLOGY, 2009, 202 (04) : 569 - 578
  • [48] Effect of Intensive Training on Mood With No Effect on Brain-Derived Neurotrophic Factor
    Piacentini, Maria Francesca
    Witard, Oliver C.
    Tonoli, Cajsa
    Jackman, Sarah R.
    Turner, James E.
    Kies, Arie K.
    Jeukendrup, Asker E.
    Tipton, Kevin D.
    Meeusen, Romain
    INTERNATIONAL JOURNAL OF SPORTS PHYSIOLOGY AND PERFORMANCE, 2016, 11 (06) : 824 - 830
  • [49] Brain-Derived Neurotrophic Factor Modulates Auditory Function in the Hearing Cochlea
    David J. Sly
    Amy J. Hampson
    Ricki L. Minter
    Leon F. Heffer
    Jack Li
    Rodney E. Millard
    Leon Winata
    Allen Niasari
    Stephen J. O’Leary
    Journal of the Association for Research in Otolaryngology, 2012, 13 : 1 - 16
  • [50] Decreased brain-derived neurotrophic factor plasma levels in psoriasis patients
    Brunoni, A. R.
    Lotufo, P. A.
    Sabbag, C.
    Goulart, A. C.
    Santos, I. S.
    Bensenor, I. M.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2015, 48 (08) : 711 - 714